179 related articles for article (PubMed ID: 36074221)
1. Clinical value of plasmablasts in predicting disease relapse in patients with IgG4-related disease.
Wang Y; Zhao Z; Gao D; Wang H; Liao S; Luo G; Ji X; Li Y; Wang X; Zhao Y; Li K; Zhang J; Jin J; Zhang Y; Zhu J; Zhang J; Huang F
Clin Rheumatol; 2023 Jan; 42(1):135-143. PubMed ID: 36074221
[TBL] [Abstract][Full Text] [Related]
2. Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial.
Wang Y; Zhao Z; Gao D; Wang H; Liao S; Dong C; Luo G; Ji X; Li Y; Wang X; Zhao Y; Li K; Zhang J; Jin J; Zhang Y; Zhu J; Zhang J; Huang F
Semin Arthritis Rheum; 2020 Dec; 50(6):1513-1520. PubMed ID: 32113839
[TBL] [Abstract][Full Text] [Related]
3. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
[TBL] [Abstract][Full Text] [Related]
4. Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse.
Lanzillotta M; Della-Torre E; Milani R; Bozzolo E; Bozzalla-Cassione E; Rovati L; Arcidiacono PG; Partelli S; Falconi M; Ciceri F; Dagna L
Arthritis Res Ther; 2018 Oct; 20(1):222. PubMed ID: 30285841
[TBL] [Abstract][Full Text] [Related]
5. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations.
Wallace ZS; Mattoo H; Carruthers M; Mahajan VS; Della Torre E; Lee H; Kulikova M; Deshpande V; Pillai S; Stone JH
Ann Rheum Dis; 2015 Jan; 74(1):190-5. PubMed ID: 24817416
[TBL] [Abstract][Full Text] [Related]
6. Examination of the Level of Circulating Plasmablasts and Their Characteristics as Diagnostic Tools for Immunoglobulin G4-related Disease.
Tartakover Matalon S; Rabinowicz N; Carmi O; Zitman-Gal T; Drucker L; Levy Y
Isr Med Assoc J; 2024 Jun; 26(6):369-375. PubMed ID: 38884310
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and therapeutic response of immunoglobulin G4-related disease: a retrospective study of 127 Chinese patients.
An W; Wu Z; Li M; Yu H; Zhao X; Wang X; Wang Y; Wang Q; Duan W; Kong Y; Ma H; Ou X; You H; Liu Y; Li P; Duan T; Jia J
Orphanet J Rare Dis; 2022 Aug; 17(1):307. PubMed ID: 35927746
[TBL] [Abstract][Full Text] [Related]
8. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.
Mattoo H; Mahajan VS; Della-Torre E; Sekigami Y; Carruthers M; Wallace ZS; Deshpande V; Stone JH; Pillai S
J Allergy Clin Immunol; 2014 Sep; 134(3):679-87. PubMed ID: 24815737
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and relapse risks factors of IgG4 related disease: a single-center retrospective study.
Zhang X; Zeng Z; Tian H; Wang N; Wang Y; Tong J; Chang B; Jin X; Huang D; Wang Y; Cui H; Guan L; Li Y
Clin Exp Med; 2023 Nov; 23(7):3527-3538. PubMed ID: 37392248
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and safety of leflunomide versus mycophenolate mofetil in treating IgG4-related disease: a retrospective cohort study.
Chen Y; Li R; Luo X; Wu T; Li J; Liu Z; Peng Y; Lu H; Peng L; Zhou J; Zhao Y; Zeng X; Fei Y; Zhang W
Clin Rheumatol; 2023 Jul; 42(7):1839-1846. PubMed ID: 36781683
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy of leflunomide and glucocorticoids for the maintenance of remission in patients with IgG4-related disease: a retrospective study and literature review.
Wang Y; Li K; Gao D; Luo G; Zhao Y; Wang X; Zhang J; Jin J; Zhao Z; Yang C; Zhu J; Zhang J; Huang F
Intern Med J; 2017 Jun; 47(6):680-689. PubMed ID: 28321964
[TBL] [Abstract][Full Text] [Related]
12. Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease.
Lanzillotta M; Della-Torre E; Milani R; Bozzolo E; Bozzalla-Cassione E; Rovati L; Arcidiacono PG; Partelli S; Falconi M; Ciceri F; Dagna L
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):159-166. PubMed ID: 30652677
[TBL] [Abstract][Full Text] [Related]
13. Serum IgE in the clinical features and disease outcomes of IgG4-related disease: a large retrospective cohort study.
Zhou J; Peng Y; Peng L; Wu D; Li J; Jiang N; Li J; Lu H; Liu Z; Luo X; Teng F; Fei Y; Zhang W; Zhao Y; Zeng X
Arthritis Res Ther; 2020 Oct; 22(1):255. PubMed ID: 33097076
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes and predictive relapse factors of IgG4-related disease following treatment: a long-term cohort study.
Peng Y; Li JQ; Zhang PP; Zhang X; Peng LY; Chen H; Zhou JX; Zhang SZ; Yang HX; Liu JJ; Guo HF; Li J; Zhang X; Zhao Y; Zeng XF; Zhang FC; Fei YY; Zhang W
J Intern Med; 2019 Nov; 286(5):542-552. PubMed ID: 31121062
[TBL] [Abstract][Full Text] [Related]
15. Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients.
Wang L; Zhang P; Wang M; Feng R; Lai Y; Peng L; Fei Y; Zhang X; Zhao Y; Zeng X; Zhang F; Zhang W
Arthritis Res Ther; 2018 Apr; 20(1):65. PubMed ID: 29636109
[TBL] [Abstract][Full Text] [Related]
16. Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease.
Kubo S; Nakayamada S; Zhao J; Yoshikawa M; Miyazaki Y; Nawata A; Hirata S; Nakano K; Saito K; Tanaka Y
Rheumatology (Oxford); 2018 Mar; 57(3):514-524. PubMed ID: 29253269
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and relapse risks of IgG4-related ophthalmic disease: a single-center experience in China.
Zhao Z; Mou D; Wang Z; Zeng Q; Wang Z; Xue J; Ren L; Liu Y; Su Y
Arthritis Res Ther; 2021 Mar; 23(1):98. PubMed ID: 33789746
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in IgG4-related disease: a long-term monocentric Chinese cohort study.
Zongfei J; Lingying M; Lijuan Z; Ying S; Rongyi C; Dongmei L; Xiufang K; Xiaomin D; Lili M; Huiyong C; Lindi J
Clin Rheumatol; 2021 Jun; 40(6):2293-2300. PubMed ID: 33151477
[TBL] [Abstract][Full Text] [Related]
19. Clinical profiles differ in IgG4-related disease with and without allergy: a large case-control study in China.
Zhao Z; Liu Y; Bai M; Zeng Q; Wang Z; Chen D; Li Z; Su Y
Clin Exp Rheumatol; 2023 Sep; 41(9):1808-1814. PubMed ID: 36826798
[TBL] [Abstract][Full Text] [Related]
20. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients.
Wallace ZS; Deshpande V; Mattoo H; Mahajan VS; Kulikova M; Pillai S; Stone JH
Arthritis Rheumatol; 2015 Sep; 67(9):2466-75. PubMed ID: 25988916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
